Open original FDA record ↗Recall record
- FDA identifier
- Z-2431-2012
- Company in FDA record
- Sekisui Diagnostics Llc
- FDA classification date
- Sep 20, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
SPECTROLYSE PAI-1 activity assay producing lower than expected absorbance values with "0" standard. This will reduce the slope of the standard curve requiring the user to make more frequent sample dilutions.
Source facts
- Action
- The firm, Sekisui Diagnostics, LLC, sent an "URGENT PRODUCTS RECALL NOTICE" dated August 28, 2012 to its customers. The notice describes the product, problem and actions to be taken. The customers were instructed to immediately stop using the product; to discard any remaining inventory and complete and return the Customer Acknowledgement Form by September 4, 2012 documenting the # of kits destroyed via FAX to Quality Assurance at 203-602-5553. The customers were also instructed to return the form even if they do not have the affected product currently in inventory. Sekisui will replace kits. If you have any questions contact, Customer Service Department at 800-637-3375, ext 10, 12, or 31, or email to recall coordinator at MKHAN@AMDIAG.COM.
- Initiated
- 2012-08-28
- Root cause
- Process control
- Terminated
- 2016-07-25
- Distribution
- Nationwide distribution: USA including states of: FL, IN, IL, and WA.
- Recall number
- Z-2431-2012
- Recall status
- Terminated
- CDRH record ID
- 112279
- FDA classified
- 2012-09-20
- Recall event number
- 63016